Category: Hepatitis

A (Lower Cost) Healthcare Industry to Deal With a (Higher Cost) Healthcare Industry

I was recently on the phone with a medical device company executive who was describing his company’s efforts to develop a non-invasive diagnostic device that could quantify the degree of cirrhosis in a patient with liver illness.  It’s technology that his firm sees as timely given the recent introduction of Solavdi and other Hepatitis C therapies: the device will be offered as a way ...

$84,000 to Treat Hepatitis C: Making Hay While the Sun Shines

There is an interesting angle to the ongoing tooth gnashing over the price of Sovaldi, Gilead Science’s breakthrough oral antiviral therapy for Hepatitis C. For those unfamiliar with the drug, Sovaldi is a recently approved treatment for chronic Hepatitis C that costs ~$84,000 and up for a course of therapy in the US (depending on ...